Inclusion Criteria:  Healthy, male or female subjects between 40 and 75 years of age. Able to read, understand and voluntarily provide written Informed Consent. Able and willing to comply with the treatment/follow-up schedule and requirements. Women of childbearing age are required to be using a reliable method of birth control at least 3 months prior to study enrollment and for the duration of the study and have a negative Urine Pregnancy test at baseline. Fitzpatrick skin type I to IV. Cheek areas are at least a score of 3 using the Lemperle Wrinkle Scale as judged by the Investigator  Exclusion Criteria:  Previous aesthetic (device and/or surgical) skin treatment (injection of dermal fillers, fat, or botulinum toxin), in the treated areas in the previous 6 months. Fat, collagen, silicone, tattoos, body jewelry, that cannot be removed for the duration of treatment and any other synthetic material in the treatment area. Scar(s) in the area to be treated. Excessive sun exposure and use of tanning beds or tanning creams within 30 days to prior to treatment History of keloid formation or hypertrophic scarring. Active smoker or having quit smoking in the last 3 months. Active, chronic, or recurrent infection Compromised immune and/or healing system (e.g., poorly controlled diabetes,) Hypersensitivity/allergy to analgesic agents, tumescent (Saline, Epinephrine, Lidocaine) Co-morbid condition that could limit the ability to participate in the study or to comply with follow-up requirements. Pregnant or breastfeeding Any indication that may cause excessive bleeding, e.g., anticoagulants or bleeding disorder. Carcinoma, melanoma, or any other cancerous condition in the last 6 months. Currently or in the last 1-month part of another clinical study of an investigational drug and/or experimental medical device Any issue that, at the discretion of the investigator would contra-indicate the subject's participation.